[Physiopathologic bases of arthrosis treatment]. 1980

P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé

UI MeSH Term Description Entries
D007249 Inflammation A pathological process characterized by injury or destruction of tissues caused by a variety of cytologic and chemical reactions. It is usually manifested by typical signs of pain, heat, redness, swelling, and loss of function. Innate Inflammatory Response,Inflammations,Inflammatory Response, Innate,Innate Inflammatory Responses
D002356 Cartilage A non-vascular form of connective tissue composed of CHONDROCYTES embedded in a matrix that includes CHONDROITIN SULFATE and various types of FIBRILLAR COLLAGEN. There are three major types: HYALINE CARTILAGE; FIBROCARTILAGE; and ELASTIC CARTILAGE. Cartilages
D002358 Cartilage, Articular A protective layer of firm, flexible cartilage over the articulating ends of bones. It provides a smooth surface for joint movement, protecting the ends of long bones from wear at points of contact. Articular Cartilage,Articular Cartilages,Cartilages, Articular
D006728 Hormones Chemical substances having a specific regulatory effect on the activity of a certain organ or organs. The term was originally applied to substances secreted by various ENDOCRINE GLANDS and transported in the bloodstream to the target organs. It is sometimes extended to include those substances that are not produced by the endocrine glands but that have similar effects. Hormone,Hormone Receptor Agonists,Agonists, Hormone Receptor,Receptor Agonists, Hormone
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D001168 Arthritis Acute or chronic inflammation of JOINTS. Oligoarthritis,Polyarthritis,Arthritides,Oligoarthritides,Polyarthritides

Related Publications

P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
January 1980, Revista espanola de reumatismo y enfermedades osteoarticulares,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
March 1971, Laval medical,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
August 1972, Therapeutische Umschau. Revue therapeutique,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
January 1956, Anales. Universidad Nacional Mayor de San Marcos. Facultad de Medicina,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
February 1971, Acta gastro-enterologica Belgica,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
January 1953, El Dia medico,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
May 1986, La Revue de medecine interne,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
October 2000, La Revue du praticien,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
October 1982, Soins; la revue de reference infirmiere,
P Franchimont, and P Gysen, and C Hauwaert, and G Heynen, and P F Zangerlé
March 1953, Arquivos brasileiros de cardiologia,
Copied contents to your clipboard!